2020
DOI: 10.1007/s00347-020-01058-w
|View full text |Cite
|
Sign up to set email alerts
|

Astigmatische Keratotomien mit dem Femtosekundenlaser

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…Classically performed in a manual (blade) manner, keratotomy with FS technology shows higher predictability and repeatability, adding the possibility of completely intrastromal incisions beyond the standard anterior penetration. 56 These designated arcuate incisions (AIs) can be performed by the FS laser at the surgeon’s predetermined depth, length, location and treatment axis; additionally, anterior penetrating AIs can be opened up manually intraoperatively or post-operatively to enhance the effect. 57 , 58 Femtosecond laser-assisted arcuate keratotomy (FSAK) is associated to less irritation, epithelial ingrowth or loss of corneal sensation, beyond diminishing the risk of infection for patients; 59 thus, it can be safely used in patients with ocular surface disease or after keratoplasty.…”
Section: Clinical Outcomesmentioning
confidence: 99%
“…Classically performed in a manual (blade) manner, keratotomy with FS technology shows higher predictability and repeatability, adding the possibility of completely intrastromal incisions beyond the standard anterior penetration. 56 These designated arcuate incisions (AIs) can be performed by the FS laser at the surgeon’s predetermined depth, length, location and treatment axis; additionally, anterior penetrating AIs can be opened up manually intraoperatively or post-operatively to enhance the effect. 57 , 58 Femtosecond laser-assisted arcuate keratotomy (FSAK) is associated to less irritation, epithelial ingrowth or loss of corneal sensation, beyond diminishing the risk of infection for patients; 59 thus, it can be safely used in patients with ocular surface disease or after keratoplasty.…”
Section: Clinical Outcomesmentioning
confidence: 99%